Stryker (SYK) Cash from Investing Activities (2009 - 2026)
Stryker (SYK) posted quarterly Cash from Investing Activities of -$639.0 million for Q2 2026, down 514.42% year-over-year from $154.2 million in Q2 2025, and down 245.41% on a QoQ basis from -$185.0 million in Q1 2026.
Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Stryker has reported Cash from Investing Activities for 18 years, with the latest figure at -$639.0 million in Q2 2026.
- Cash from Investing Activities for Q2 2026 came in at -$639.0 million, down 514.42% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.5 billion (up 78.41% YoY), and the FY2025 annual result was -$4.9 billion, down 62.2% from the prior year.
- Cash from Investing Activities slipped to -$639.0 million in Q2 2026, from -$185.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
- A 5-year average of -$698.7 million and a median of -$244.0 million in 2024 frame the typical range for Cash from Investing Activities.
- The largest YoY upside for Cash from Investing Activities was 129.15% in 2022 against a maximum downside of 2693.75% in 2022.
- A 5-year view of Cash from Investing Activities shows it stood at -$162.0 million in 2022, then grew by 6.17% to -$152.0 million in 2023, then slumped by 99.34% to -$303.0 million in 2024, then slipped by 0.66% to -$305.0 million in 2025, then sank by 109.51% to -$639.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$639.0 million in Q2 2026, -$185.0 million in Q1 2026, and -$305.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -639.00 Mn |
| Jun 30, 2026 | -639.00 Mn |
| Mar 31, 2026 | -185.00 Mn |
| Mar 31, 2026 | -185.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Sep 30, 2025 | -321.00 Mn |
| Sep 30, 2025 | -321.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Mar 31, 2025 | -4.14 Bn |
| Mar 31, 2025 | -4.14 Bn |
| Dec 31, 2024 | -303.00 Mn |
| Dec 31, 2024 | -303.00 Mn |
| Sep 30, 2024 | -2.17 Bn |
| Sep 30, 2024 | -2.17 Bn |
| Jun 30, 2024 | -117.00 Mn |
| Jun 30, 2024 | -117.00 Mn |
| Mar 31, 2024 | -408.00 Mn |
| Mar 31, 2024 | -408.00 Mn |